Hu L - Search Results

1

Therapeutic drug monitoring of voriconazole and CYP2C19 phenotype for dose optimization in paediatric patients.

Hu L, Huang Q, Huang S, Feng Z. Hu L, et al. Eur J Clin Pharmacol. 2023 Sep;79(9):1271-1278. doi: 10.1007/s00228-023-03538-9. Epub 2023 Jul 17. Eur J Clin Pharmacol. 2023. PMID: 37458772

2

Therapeutic Drug Monitoring of Voriconazole in Children from a Tertiary Care Center in China.

Hu L, Dai TT, Zou L, Li TM, Ding XS, Yin T. Hu L, et al. Antimicrob Agents Chemother. 2018 Nov 26;62(12):e00955-18. doi: 10.1128/AAC.00955-18. Print 2018 Dec. Antimicrob Agents Chemother. 2018. PMID: 30150475 Free PMC article.

3

A novel reversed-phase high-performance liquid chromatographic assay for the simultaneous determination of imipenem and meropenem in human plasma and its application in TDM.

Zou L, Meng F, Hu L, Huang Q, Liu M, Yin T. Zou L, et al. Among authors: hu l. J Pharm Biomed Anal. 2019 May 30;169:142-150. doi: 10.1016/j.jpba.2019.01.039. Epub 2019 Jan 31. J Pharm Biomed Anal. 2019. PMID: 30861406

4

Effect of proton pump inhibitors on voriconazole concentrations in Chinese patients with malignant hematological diseases.

Huang Q, Liu Q, Yin T, Hu L, Ding H, Liu S, Jiang Y. Huang Q, et al. Among authors: hu l. Eur J Clin Pharmacol. 2020 Jun;76(6):833-842. doi: 10.1007/s00228-020-02841-z. Epub 2020 Mar 10. Eur J Clin Pharmacol. 2020. PMID: 32157329

5

Population pharmacokinetics of voriconazole and the role of CYP2C19 genotype on treatment optimization in pediatric patients.

Hu L, Huang S, Huang Q, Huang J, Feng Z, He G. Hu L, et al. PLoS One. 2023 Sep 11;18(9):e0288794. doi: 10.1371/journal.pone.0288794. eCollection 2023. PLoS One. 2023. PMID: 37695751 Free PMC article.

6

Clinical application of voriconazole in pediatric patients: a systematic review.

Hu L, Huang J, Li Y, He G. Hu L, et al. Ital J Pediatr. 2024 Jun 9;50(1):113. doi: 10.1186/s13052-024-01684-z. Ital J Pediatr. 2024. PMID: 38853280 Free PMC article. Review.

7

Therapeutic drug monitoring and safety of voriconazole in patients with liver dysfunction.

Hu L, Su Y, Tang X, Li Y, Feng J, He G. Hu L, et al. Antimicrob Agents Chemother. 2024 Nov 6;68(11):e0112624. doi: 10.1128/aac.01126-24. Epub 2024 Oct 21. Antimicrob Agents Chemother. 2024. PMID: 39431818

8

Risks of malignancies related to disease-modifying antirheumatic drugs in rheumatoid arthritis: a pharmacovigilance analysis using the FAERS database.

Xiong W, Li Y, Hu L, He G, Huang J. Xiong W, et al. Among authors: hu l. Front Pharmacol. 2024 Nov 13;15:1458500. doi: 10.3389/fphar.2024.1458500. eCollection 2024. Front Pharmacol. 2024. PMID: 39605908 Free PMC article.

9

Ocular adverse events associated with antibody-drug conjugates: a comprehensive pharmacovigilance analysis.

Chen H, He G, Huang J, Hu L, Ma J. Chen H, et al. Among authors: hu l. Front Immunol. 2024 Dec 17;15:1495137. doi: 10.3389/fimmu.2024.1495137. eCollection 2024. Front Immunol. 2024. PMID: 39742259 Free PMC article.

10

A novel analytical method to assess the effect of imipenem/cilastatin on liver function laboratory indexes in Chinese underage inpatients: Probability distribution curve.

Zou L, Meng F, Wang W, Ye Q, Hu L, Li T, Yin T. Zou L, et al. Among authors: hu l. PLoS One. 2019 Oct 24;14(10):e0224352. doi: 10.1371/journal.pone.0224352. eCollection 2019. PLoS One. 2019. PMID: 31648284 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16,067 results

Search Page

Filters